Larvol Delta - Adlai-Nortye-Announces-First-Patient-Enrolled-in-Global-Phase-1-Trial-of-PanRAS-ON-Inhibitor-AN9025-for-Solid-Tumors-Harboring-RAS-Mutations

AN9025 - Adlai Nortye

https://www.globenewswire.com/news-release/2026/02/12/3236924/0/en/Adlai-Nortye-Announces-First-Patient-Enrolled-in-Global-Phase-1-Trial-of-Pan-RAS-ON-Inhibitor-AN9025-for-Solid-Tumors-Harboring-RAS-Mutations.html

Feb 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next